Prospective Evaluation of Liver Function Tests in Patients Treated with Aminoglycosides
- 1 February 1990
- journal article
- research article
- Published by SAGE Publications in DICP
- Vol. 24 (2) , 135-137
- https://doi.org/10.1177/106002809002400203
Abstract
We investigated the relationship between therapy with aminoglycoside antibiotics and alterations in serum liver enzymes and bilirubin. One hundred fourteen patients treated with aminoglycosides and 96 treated with other antibiotics were assessed prospectively during eight days. No elevation in serum alanine aminotransferase, lactic dehydrogenase, or bilirubin was detected in the aminoglycoside and control groups. Alkaline phosphatase increased significantly in the aminoglycoside group (average elevation of 28 ± 16 units/L on day 6), but no patient had an elevation greater than twice the upper limit of the normal range. We conclude that the abnormality in liver enzymes during aminoglycoside therapy is a mild elevation in alkaline phosphatase, probably with no clinical significance.This publication has 6 references indexed in Scilit:
- Acute Hepatocellular Effects of Erythromycin, Gentamicin, and Trospectomycin in the Perfused Rat Liver: Lack of Correlation between Lamellar Body Induction Potency and CytotoxicityBasic & Clinical Pharmacology & Toxicology, 1988
- Drug NephrotoxicityAnnual Review of Pharmacology and Toxicology, 1988
- Hepatic dysfunction during bacterial sepsisIntensive Care Medicine, 1987
- Tobramycin Side Effects-International ResultsScottish Medical Journal, 1976
- Clinical Experience with Gentamicin in JapanThe Journal of Infectious Diseases, 1969
- Gentamicin: Pharmacologic Observations in Newborns and InfantsThe Journal of Infectious Diseases, 1969